Clinical Trial Update: Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study of exatecan mesylate in patients with advanced soft tissue sarcoma, with the study status shown as complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Exatecan Mesylate (exatecan mesylate)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Sarcoma | Phase 2 | Status: COMPLETED